Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)
Others
Ratios

BioNexus Gene Lab (BGLC) Research & Development (2024 - 2025)

Historic Research & Development for BioNexus Gene Lab (BGLC) over the last 2 years, with Q3 2025 value amounting to $14876.0.

  • BioNexus Gene Lab's Research & Development rose 4246.31% to $14876.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $56968.0, marking a year-over-year change of. This contributed to the annual value of $47511.0 for FY2024, which is 1358.81% down from last year.
  • BioNexus Gene Lab's Research & Development amounted to $14876.0 in Q3 2025, which was up 4246.31% from $12557.0 recorded in Q2 2025.
  • BioNexus Gene Lab's 5-year Research & Development high stood at $17396.0 for Q4 2024, and its period low was $8198.0 during Q2 2024.